Liu L - Search Results

1

Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.

Tian P, He B, Mu W, Liu K, Liu L, Zeng H, Liu Y, Jiang L, Zhou P, Huang Z, Dong D, Li W. Tian P, et al. Among authors: liu k, liu y, liu l. Theranostics. 2021 Jan 1;11(5):2098-2107. doi: 10.7150/thno.48027. eCollection 2021. Theranostics. 2021. PMID: 33500713 Free PMC article.

2

In(III)-catalyzed tandem reaction of chromone-derived Morita-Baylis-Hillman alcohols with amines.

Wu C, Liu Y, Zeng H, Liu L, Wang D, Chen Y. Wu C, et al. Among authors: liu y, liu l. Org Biomol Chem. 2011 Jan 7;9(1):253-6. doi: 10.1039/c0ob00604a. Epub 2010 Nov 3. Org Biomol Chem. 2011. PMID: 21049104

3

An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy.

Li L, Yang S, Song L, Zeng Y, He T, Wang N, Yu C, Yin T, Liu L, Wei X, Wu Q, Wei Y, Yang L, Gong C. Li L, et al. Among authors: liu l. Theranostics. 2018 Jan 1;8(3):860-873. doi: 10.7150/thno.19826. eCollection 2018. Theranostics. 2018. PMID: 29344312 Free PMC article.

4

Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.

Cao R, Yang F, Ma SC, Liu L, Zhao Y, Li Y, Wu DH, Wang T, Lu WJ, Cai WJ, Zhu HB, Guo XJ, Lu YW, Kuang JJ, Huan WJ, Tang WM, Huang K, Huang J, Yao J, Dong ZY. Cao R, et al. Among authors: liu l. Theranostics. 2020 Sep 2;10(24):11080-11091. doi: 10.7150/thno.49864. eCollection 2020. Theranostics. 2020. PMID: 33042271 Free PMC article.

5

Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.

Shi Y, Lei Y, Liu L, Zhang S, Wang W, Zhao J, Zhao S, Dong X, Yao M, Wang K, Zhou Q. Shi Y, et al. Among authors: liu l. Cancer Med. 2021 Apr;10(7):2216-2231. doi: 10.1002/cam4.3649. Epub 2021 Mar 2. Cancer Med. 2021. PMID: 33655698 Free PMC article.

6

Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors.

Xiao LS, Li QM, Hu CY, Cui H, Hong C, Huang CY, Li RN, Dong ZY, Zhu HB, Liu L. Xiao LS, et al. Among authors: liu l. Ann Palliat Med. 2021 Nov;10(11):11244-11254. doi: 10.21037/apm-21-2023. Epub 2021 Oct 11. Ann Palliat Med. 2021. PMID: 34670386 Free article.

7

SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response.

Zong Y, Li Q, Zhang F, Xian X, Wang S, Xia J, Li J, Tuo Z, Xiao G, Liu L, Li G, Zhang S, Wu G, Liu J. Zong Y, et al. Among authors: liu j, liu l. Theranostics. 2019 Aug 14;9(22):6380-6395. doi: 10.7150/thno.34443. eCollection 2019. Theranostics. 2019. PMID: 31588224 Free PMC article.

8

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study.

Xiao LS, Li RN, Cui H, Hong C, Huang CY, Li QM, Hu CY, Dong ZY, Zhu HB, Liu L. Xiao LS, et al. Among authors: liu l. BMC Cancer. 2022 Jul 6;22(1):737. doi: 10.1186/s12885-022-09823-7. BMC Cancer. 2022. PMID: 35794525 Free PMC article.

9

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice.

Ma SC, Bai X, Guo XJ, Liu L, Xiao LS, Lin Y, Tan JL, Cai XT, Wen YX, Ma H, Fu QJ, Leng MX, Zhang YP, Long LL, Guo ZQ, Wu DH, Zhou JG, Dong ZY. Ma SC, et al. Among authors: liu l. BMC Med. 2022 Apr 12;20(1):120. doi: 10.1186/s12916-022-02315-2. BMC Med. 2022. PMID: 35410334 Free PMC article.

10

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study.

Zhang Y, Song L, Zeng L, Xiong Y, Liu L, Zhou C, Yang H, Wang Z, Xia Q, Jiang W, Xu Q, Yang N. Zhang Y, et al. Among authors: liu l. BMC Cancer. 2022 Sep 5;22(1):952. doi: 10.1186/s12885-022-10045-0. BMC Cancer. 2022. PMID: 36064386 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,264 results

Search Page

Filters